Vimarsana
Biggest News Aggregation in the World

Colitis Study News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Colitis Study. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Colitis Study Today - Breaking & Trending Today

Matinas BioPharma Demonstrates in vivo Biological Activity and Disease Improvement in Two Inflammatory Disease Models with Oral LNC-Delivered Small Oligonucleotides - Vimarsana News

Matinas BioPharma Demonstrates in vivo Biological Activity and Disease Improvement in Two Inflammatory Disease Models with Oral LNC-Delivered Small Oligonucleotides

Published: December 27, 2023

In an acute colitis model, data show statistically significant knockdown of elevated levels of serum TNFα, reductions in tissue TNFα mRNA and improvement in disease activity scores In an acute...

Source: marketscreener.com
Related Topics:
United StatesJody CainJeromed JabbourMatinas BiopharmaJames FergusonMatinas Biopharma Holdings IncBiopharma HoldingsMatina Chief MedicalColitis StudyPsoriasis StudyChief Executive OfficerPrivate Securities Litigation Reform Act
Why Is Inflammatory Focused Matinas BioPharma (MTNB) Stock Trading Higher Today? - Matinas BioPharma Hldgs (AMEX:MTNB) - Vimarsana News

Why Is Inflammatory Focused Matinas BioPharma (MTNB) Stock Trading Higher Today? - Matinas BioPharma Hldgs (AMEX:MTNB)

Published: December 27, 2023

Wednesday, Matinas BioPharma Holdings Inc (NASDAQ: MTNB) announced results from a series of in vivo studies demonstrating successful oral delivery of two lipid nanocrystal (LNC)-formulated small single-strand oligonucleotides targeting inflammatory cytokines TNFα and IL-17

Source: benzinga.com
Related Topics:
Matinas Biopharma Holdings IncMatinas Biopharma HoldingsColitis StudyPsoriasis Study